Results 131 to 140 of about 200,643 (293)

Systemic Immunosuppression to Reduce Surgical Intervention in ANCA‐Negative Subglottic Stenosis

open access: yesThe Laryngoscope, EarlyView.
Idiopathic subglottic stenosis (iSGS) typically follows an indolent course managed with surgical dilatation, though a subset demonstrates aggressive, recurrent disease. In this retrospective cohort study, systemic immunosuppression significantly prolonged inter‐dilation intervals in both granulomatosis with polyangiitis‐associated SGS and an “atypical”
Guy Benshetrit   +5 more
wiley   +1 more source

Cochlear Implantation in Autoimmune Inner‐Ear Disease: Outcome and Patient‐Reported Benefit

open access: yesThe Laryngoscope, EarlyView.
This study demonstrates that patients with secondary autoimmune inner‐ear disease (AIED) achieve significant improvements in speech perception and quality of life following cochlear implantation. Although AIED patients may show slightly lower performance in noisy environments compared to controls, their subjective hearing benefit converges with matched
Merete Hartmann   +4 more
wiley   +1 more source

Psychometric Validation of the Overall Symptom Severity Score for Chronic Rhinosinusitis

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective Overall symptom severity (OSS) is a global metric of chronic rhinosinusitis (CRS) symptom severity. We sought to establish psychometric validity for the OSS, which has not been previously demonstrated in the literature. Study Design Prospective, observational. Setting Academic medical center. Methods Adult patients with CRS (N = 647)
Christine W. Lee   +5 more
wiley   +1 more source

The evolving role of regulatory T cells in Sjögren's disease pathogenesis and the promise of Treg‐based therapies: A comprehensive review

open access: yesRheumatology &Autoimmunity, EarlyView.
Graphical Abstract The evolving role of regulatory T cells in primary Sjögren's disease pathogenesis and the promise of Treg‐based therapies. Abstract Sjögren's disease (SjD) is a chronic systemic autoimmune disorder characterised by exocrine gland dysfunction and diverse systemic manifestations.
Gagan Urs   +5 more
wiley   +1 more source

A Rapidly Progressive Necrotic Ulcer in an Immunocompromised Patient

open access: yes
JEADV Clinical Practice, EarlyView.
R. Almutairi   +5 more
wiley   +1 more source

Clinical characteristics of immediate allergic adverse reactions to intravenous amoxicillin‒clavulanic acid in conscious dogs

open access: yesVeterinary Record, EarlyView.
Abstract Background Amoxicillin‒clavulanic acid (AMC) is one of the most frequently used antibiotics in small animal practice, and reports on adverse reactions are scarce. The aim of this study was to describe the clinical characteristics of immediate allergic adverse reactions to intravenous (IV) AMC in conscious dogs. Methods The medical records of a
Leonel Frutuoso, Anna Threlfall
wiley   +1 more source

Hepatitis-C-associated multiple arterial dissection of cerebral vessels [PDF]

open access: yes, 2003
Einsiedel, H. von   +3 more
core   +1 more source

Healthcare Resource Utilization and Use of Biologics in Chronic Spontaneous Urticaria

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Biologic therapies have emerged as effective treatments for chronic spontaneous urticaria (CSU), a debilitating skin disease. However, real‐world data on their use are limited. This retrospective descriptive study analyzes the time from diagnosis to biologic therapy initiation and the CSU‐specific healthcare resource utilization (HCRU) among ...
Lillian D. Sun   +7 more
wiley   +1 more source

Retinal Vasculitis [PDF]

open access: yesOcular Immunology and Inflammation, 2020
Emmett T, Cunningham, Manfred, Zierhut
openaire   +2 more sources

Unmet Needs in Treatment Escalation for Chronic Spontaneous Urticaria: Findings From the CURE Registry

open access: yesAllergy, EarlyView.
Appropriate treatment escalation improves CSU disease control. However, only about a quarter of patients achieve a complete response, the main goal of CSU treatment. Approximately one‐third of patients clinically eligible for escalation (UCT < 12) do not receive guideline‐recommended treatment escalation and remain symptomatic on their current ...
Pavel Kolkhir   +25 more
wiley   +1 more source

Home - About - Disclaimer - Privacy